Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs

Epidermal growth factor receptor (EGFR) exon 19 deletion (E19del) is the most common activating mutation in advanced non–small cell lung cancer (NSCLC) and associates with the sensitivity of EGFR tyrosine kinase inhibitors (TKIs) treatment. However, not all mutant patterns of E19del have been well s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Oncol
Autors principals: Xu, Chun-wei, Lei, Lei, Wang, Wen-xian, Lin, Li, Zhu, You-cai, Wang, Hong, Miao, Li-yun, Wang, Li-ping, Zhuang, Wu, Fang, Mei-yu, Lv, Tang-feng, Song, Yong
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2020
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7264750/
https://ncbi.nlm.nih.gov/pubmed/32492620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100791
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars